Skip to main content
. 2004 Jun;136(3):423–431. doi: 10.1111/j.1365-2249.2004.02467.x

Table 4.

Increased levels of proinflammatory cytokines in neonatal thymectomized mice treated with poly I:C

n IL-10 (pg/ml) IL-6 (pg/ml) MCP-1 (pg/ml) IFN-γ (pg/ml) TNF-α (pg/ml) IL-12p70 (pg/ml)
(a)Poly I:C-treated thymectomized 3 36·5 ± 12·6 368·3 ± 115·4* 303·5 ± 61·9* 25·8 ± 9·0* 72·5 ± 14·5* 268·6 ± 121·9*
(b)Poly I:C-treated nonthymectomized 3 33·7 ± 9·2 250·1 ± 115·2* 200·6 ± 49·0* 19·8 ± 2·0* 59·1 ± 16·0* 165·5 ± 92·6*
(c)PBS-treated thymectomized 3 17·0 ± 10·2 143·1 ± 86·0 96·7 ± 33·8 10·0 ± 6·2 33·5 ± 14·1 56·4 ± 25·2

BALB/c mice were thymectomized on day 3 after birth (a, c) or remained untreated (b). Neonatal thymectomized mice received either poly I:C (a) or PBS (c), twice in a week for 4 consecutive weeks. Non-thymectomized mice received poly I:C (b). All mice were killed 4 weeks after thymectomy or poly I:C administration. The levels of cytokines in the sera were estimated by CBA method.

*

P < 0·05 compared to PBS-treated thymectomized mice.